Lilly Eli News - LLY

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$44.59
Canadian Level 1 + USA
Monthly Subscription
for only
$34.59
ULTIMATE TRADER
Monthly Subscription
for only
$72.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Eli Lilly And Company LLY NYSE Ordinary Share US5324571083
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.42 -0.5% 83.89 84.34 83.71 84.12 84.31 16:38:48
more quote information »
Industry Sector
Drug Manufacturers - Major

Recent News

Date Time Source Heading
6/23/201710:17EDGARStatement of Changes in Beneficial Ownership (4)
6/21/201715:41EDGARStatement of Changes in Beneficial Ownership (4)
6/21/201713:45EDGARAmended Current Report Filing (8-k/a)
6/21/201711:25EDGARStatement of Changes in Beneficial Ownership (4)
6/21/201711:00PRNUSEli Lilly and Company Unveils Expanded Biotechnology Center..
6/19/201713:59PRNUSLilly Declares Third-Quarter 2017 Dividend
6/19/201713:05PRNUSLilly Declares Third-Quarter 2017 Dividend
6/19/201708:11PRNUSLilly and NRAS Launch New Film for RA Awareness Week to..
6/16/201705:10PRNCAEULAR 2017: Lilly's Taltz® (ixekizumab) Demonstrated No..
6/16/201705:10PRNUSEULAR 2017: Lilly's Taltz® (ixekizumab) Demonstrated No..
6/16/201704:15PRNCANew Safety and Long-Term Efficacy Data from Baricitinib..
6/16/201704:15PRNUSNew Safety and Long-Term Efficacy Data from Baricitinib..
6/16/201701:00PRNUSEli Lilly and Company: RA Matters Survey Uncovers What..
6/15/201710:35PRNCAEULAR 2017: Lilly's Taltz® (ixekizumab) Demonstrated..
6/15/201710:35PRNUSEULAR 2017: Lilly's Taltz® (ixekizumab) Demonstrated..
6/13/201718:01PRNUSLilly to Present New Data on Olumiant® (baricitinib) in..
6/13/201716:16EDGARInitial Statement of Beneficial Ownership (3)
6/13/201716:12EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201714:00PRNUSJardiance® (empagliflozin) analysis reinforces established..
6/13/201708:00BWPfizer and Lilly Receive FDA Fast Track Designation for..
6/12/201715:00PRNUSElanco Releases First-Ever Corporate Social Responsibility..
6/12/201708:00PRNUSJardiance® (empagliflozin) tablets to be studied in chronic..
6/12/201702:57DJNHutchison China Submits New Cancer Drug Application
6/10/201710:00PRNUSLilly's Galcanezumab Significantly Reduces Number of..
6/09/201716:16EDGARStatement of Changes in Beneficial Ownership (4)
6/09/201706:30PRNUSIDF, in partnership with Lilly, announces second phase of..
6/08/201715:25PRNUSLilly to Present Late-Breaking Data for Galcanezumab and..
6/08/201715:00PRNUSLilly Announces Webcast to Discuss Pain Management Portfolio
6/08/201706:30PRNUSLilly Announces Strategic Collaboration with KeyBioscience..
6/07/201712:23PRNUSNews Alert: Blink Health To Give Away $10 Million Worth Of..
6/07/201708:00PRNUSBlink Health Commits To Give Away $10 Million Worth Of Free..
6/03/201714:15PRNUSLilly Builds Upon Body of Data for Abemaciclib with Phase 3..
6/02/201703:02DJNEli Lilly's CFO Plans To Retire -- WSJ
6/01/201711:38DJNEli Lilly Financial Chief to Retire After 11 Years in..
6/01/201708:30PRNUSBoehringer Ingelheim and Lilly Diabetes Alliance to Present..
6/01/201708:25DJNEli Lilly Financial Chief to Retire After 11 Years in Role
6/01/201707:07EDGARCurrent Report Filing (8-k)
6/01/201706:45PRNUSDerica Rice to Retire as Lilly Chief Financial Officer
6/01/201706:45PRNUSDerica Rice to Retire as Lilly Chief Financial Officer
5/31/201714:30PRNUSLilly to Participate in Goldman Sachs Global Healthcare..
5/31/201706:45PRNUSLilly Announces Phase 3 RANGE Urothelial Cancer Trial of..
5/30/201712:49EDGARSpecialized Disclosure Report (sd)
5/24/201707:00PRNUSElanco Animal Health Works to Bring Products to Small Holder..
5/17/201717:00PRNUSLilly to Present Results from Pivotal Breast Cancer Study of..
5/17/201714:48EDGARStatement of Changes in Beneficial Ownership (4)
5/17/201714:43EDGARStatement of Changes in Beneficial Ownership (4)
5/16/201707:30PRNUSActress Angela Bassett joins For Your SweetHeart™ to urge..
5/12/201709:13DJNLilly's New Migraine Drug Shows Positive Results
5/12/201706:45PRNCALilly Announces Positive Results for Three Phase 3 Studies..
5/12/201706:45PRNUSLilly Announces Positive Results for Three Phase 3 Studies..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.